tiprankstipranks
Trending News
More News >
Corcept Therapeutics (CORT)
:CORT
Advertisement

Corcept Therapeutics (CORT) Revenue

Compare
1,051 Followers

Corcept Therapeutics Revenue

Corcept Therapeutics had a revenue of 194.43M in the quarter ending Jun 30, 2025, with 23.67%. This bring the company's revenue in the last twelve months to 716.08M, Decreased 4.47%. In the fiscal year ending Dec 31, 2024, Corcept Therapeutics had annual revenue of 675.04M with 39.94% growth.
Revenue (ttm)
716.08M
Revenue Growth
25.71%
P/S Ratio
10.77
Revenue/Employee
$1,350,080
Employees
500
Market Cap
$7.27B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
675.04M192.66M+39.94%
Dec 31, 2023
482.38M80.52M+20.04%
Dec 31, 2022
401.86M35.88M+9.80%
Dec 31, 2021
365.98M12.10M+3.42%
Dec 31, 2020
353.87M47.39M+15.46%
Dec 31, 2019
306.49M55.24M+21.99%
Dec 31, 2018
251.25M92.05M+57.82%
Dec 31, 2017
159.20M77.88M+95.77%
Dec 31, 2016
81.32M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis